Takeshi Kishida

机构：Kanagawa Prefectural Hospital Organization, Kanagawa Cancer Center · ORCID：0000-0002-6016-108X

发表论文 293 篇 · 总被引 9106 次 · h-index 47

代表论文

• Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study (2024 · Journal of Clinical Oncology · 被引 177)
• Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation (2024 · Computational and Structural Biotechnology Journal · 被引 19)
• MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors (2024 · International Journal of Clinical Oncology · 被引 7)
• Sexual function using the EORTC QLQ‐TC26 in testicular cancer survivors: A multi‐institutional, cross‐sectional study (2023 · International Journal of Urology · 被引 7)
• Short-term outcomes of triplet therapy in metastatic hormone-sensitive prostate cancer in older adults: a retrospective, single-center real-world cohort study (2025 · International Urology and Nephrology · 被引 6)
• Combination of Blood Adiponectin and Leptin Levels Is a Predictor of Biochemical Recurrence in Prostate Cancer Invading the Surrounding Adipose Tissue (2024 · International Journal of Molecular Sciences · 被引 5)